Literature DB >> 28668376

Clinical characteristics, beta-cell dysfunction and treatment outcomes in patients with A-β+ Ketosis-Prone Diabetes (KPD): The first identified cohort amongst Asian Indians.

Riddhi Das Gupta1, Roshna Ramachandran2, Praveen Gangadhara2, Shajith Anoop2, Surjitkumar H Singh3, Anil Satyaraddi2, Samantha Sathyakumar2, H S Asha2, Nihal Thomas4.   

Abstract

OBJECTIVE: Ketosis-prone diabetes (KPD), an atypical form of diabetes, has emerged as a heterogeneous syndrome in multiple ethnic groups. The objectives of this study were to look into the clinical characteristics of adult Asian Indian patients with recently diagnosed, antibody negative diabetes presenting with unprovoked ketoacidosis (A-β+ KPD) and to determine the natural course of recovery of beta-cell functions on serial follow-up over one year. RESEARCH DESIGN AND METHODS: Newly diagnosed adult diabetes patients (n=11) with suspected KPD (A-β+) were prospectively studied over a period of 1-year with serial evaluations of clinical, biochemical and beta-cell secretion characteristics. These were compared with a control group (n=23) of KPD (A+β-) (classical Type 1A diabetes) with similar presentation. Beta-cell secretion was assessed by fasting and stimulated C-peptide values after a standard mixed meal challenge. Glycaemic control and treatment outcomes were also documented.
RESULTS: In comparison to the A+β- KPD controls, the A-β+ KPD patients had a significantly older age, higher BMI, stronger family history of type 2 diabetes, more severe ketoacidosis and higher fasting and stimulated C-peptide level at presentation. On serial follow-up, the patients with KPD achieved complete recovery of their beta-cell function with remission from insulin-dependence within 3-4months without further recurrences of DKA.
CONCLUSIONS: This is the first reported series of A-β+ KPD from India. The phenotype of Indian A-β+ KPD patients differs from their Western counterparts in that they are relatively younger and leaner, though the male preponderance and natural history of recovery of beta-cell dysfunction bears similarity.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asian Indians; Beta-cell function; C-peptide; Ketoacidosis; Ketosis-prone diabetes

Mesh:

Substances:

Year:  2017        PMID: 28668376     DOI: 10.1016/j.jdiacomp.2017.06.008

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  8 in total

1.  Prevalence and Gender Differences of Metabolic Syndrome in Young Ketosis-Prone Type 2 Diabetic Individuals: A Retrospective Study.

Authors:  Shichun Du; Hongmei Zhang; Hui Wu; Shu Ye; Wen Li; Qing Su
Journal:  Diabetes Metab Syndr Obes       Date:  2020-08-03       Impact factor: 3.168

Review 2.  Toward an Improved Classification of Type 2 Diabetes: Lessons From Research into the Heterogeneity of a Complex Disease.

Authors:  Maria J Redondo; Ashok Balasubramanyam
Journal:  J Clin Endocrinol Metab       Date:  2021-11-19       Impact factor: 6.134

3.  Non-immune-mediated versus immune-mediated type 1 diabetes: diagnosis and long-term differences-retrospective analysis.

Authors:  Diana Catarino; Diana Silva; Joana Guiomar; Cristina Ribeiro; Luísa Ruas; Luís Cardoso; Isabel Paiva
Journal:  Diabetol Metab Syndr       Date:  2020-07-06       Impact factor: 3.320

Review 4.  Ketosis-Prone Diabetes (Flatbush Diabetes): an Emerging Worldwide Clinically Important Entity.

Authors:  Harold E Lebovitz; Mary Ann Banerji
Journal:  Curr Diab Rep       Date:  2018-10-02       Impact factor: 4.810

5.  Ketosis-prone diabetes mellitus in an obese adolescent: A case report.

Authors:  Huiwen Tan; Chun Wang; Yerong Yu
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

6.  Elevated Serum Triglycerides are Associated with Ketosis-Prone Type 2 Diabetes in Young Individuals.

Authors:  Shu Ye; Hui Ran; Hongmei Zhang; Hui Wu; Wen Li; Shichun Du; Qing Su
Journal:  Diabetes Metab Syndr Obes       Date:  2021-02-04       Impact factor: 3.168

7.  A Cross-Sectional Study of Atherosclerosis in Newly Diagnosed Patients with Ketosis-Prone Type 2 Diabetes.

Authors:  Yuxia Wang; Chaoyin Lu; Mauro Augusto Monteiro Cardoso Lopes; Lingqiao Chen; Yan Luo; Wenjun Wu; Xuemei Gu
Journal:  Diabetes Metab Syndr Obes       Date:  2022-03-25       Impact factor: 3.168

8.  Clinical and Biochemical Characteristics and Treatment Outcomes of Ketosis-Prone Diabetes: The Remission Prone Diabetes.

Authors:  Swaraj Shrikant Waddankeri; Meenakshi Swaraj Waddankeri; Basavraj Gurushantappa Mangshetty
Journal:  Int J Endocrinol Metab       Date:  2021-03-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.